Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
126021341	12602134	1	I	20160707	0	20160727	20160727	DIR					70.00	YR		M	N	124.10000	KG	20160718	N	PH	US

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	LOT NUM	EXP DT	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
126021341	12602134	1	PS	ASPIRIN.	ASPIRIN	1	Oral				N	D			0	325	MG		QD
126021341	12602134	2	SS	CLOPIDOGREL	CLOPIDOGREL BISULFATE	1	Oral				N	D			0	75	MG		QD

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
126021341	12602134	1	Peripheral vascular disorder
126021341	12602134	2	Peripheral vascular disorder

Outcome of event

Event ID	CASEID	OUTC COD
126021341	12602134	HO

Reactions reported

Event ID	CASEID	PT
126021341	12602134	Anaemia
126021341	12602134	Gastric ulcer haemorrhage
126021341	12602134	Gastrointestinal stromal tumour
126021341	12602134	Haematemesis
126021341	12602134	Haemodialysis complication

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID	CASEID	RPSR COD
126021341	12602134	HP

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
126021341	12602134	1	19970918	20160701	0
126021341	12602134	2	20100908	20160701	0